Benzodiazepines More than a dozen benzodiazepines are marketed in the US.
{"Image DocumentName": "BenzodiazepinesMore than a dozen benzodiazepines are marketed in the US.", "Image ImageDescription": "They are distinguished primarily by their profiles of distribution and half-life. Toxicity is mainly excessive sedation. After chronic use, withdrawal seizures may occur, especially with short half-life agents.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}